The Eosinophil Clinical Research Unit develops translational and clinical protocols for study of eosinophilic disorders. Through comprehensive trainee and investigator mentoring as well as partnering with highly trained research coordinators, nurses, clinical providers, as well as patient advocates and research participants, ECRU oversees and implements protocols to study a range of eosinophil-related disorders. The types of protocols implemented include novel diagnostic, therapeutic, and interventional approaches to study of eosinophil associated pathogenesis. The eosinophil clinical research unit also studies the application of augmented intelligence/machine learning approaches in allergic and immunologic diseases.
Paneez Khoury, M.D., M.H.Sc., FAAAAI (She/Her/Hers)
Senior Clinician; Director, Allergy & Immunology Fellowship Training Program, Laboratory of Allergic Diseases (LAD)
Head, Eosinophil Clinical Research Unit, Human Eosinophil Section, Laboratory of Parasitic Diseases (LPD)
Specialty(s): Allergy and Immunology, Internal Medicine Provides direct clinical care to patients at NIH Clinical Center
M.D., University of Illinois College of Medicine, Chicago, IL
M.H.Sc., Duke University, Durham, NC
Amari Howard, M.D. (She/Her/Hers)
Residency, Jefferson/A.I. DuPoint
Medical School, University of Pittsburgh
Undergraduate, Syracuse University
Dr. Amari Howard is a gastroenterology fellow trainee at Children’s National Medical Center performing research in the eosinophil clinical research unit. Her clinical and research interests are in IBD and EGIDs. She is involved in the development and implementation of a CEGIR/NCATS funded pilot assessment of gastric motility abnormalities in patients with eosinophilic gastritis.
Meghan Koch, B.S. (She/Her/Hers)
B.S., Colorado College